Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Pediatr Nephrol. 2017 Feb 15;32(7):1181–1192. doi: 10.1007/s00467-017-3590-y

Table 5.

Causative mutation distribution among different renal biopsy findings

Biopsy pattern No biopsy performed or no data
FSGS MCD MsPGN Sclerosing glomerulonephritis Others#
Patients, no. 42 16 7 3 11 41
Patients with identified mutation, no. (%) 12 (28.6%) 1 (6.3%) 3 (42.9%) 1 (33.3%) 0 17 (41.5%)

FSGS, focal segmental glomerulosclerosis; MCD, minimal change disease; MsPGN: mesangioproliferative glomerulonephritis; #: included 5 patients with membranous glomerulonephritis, 3 patients with IgM nephropathy, 1 patient with C3 nephropathy, 1 patient with IgA nephropathy and 1 patient with membranoproleferative glomerulonephritis.